Earnings
NRIX
15.60
-0.83%
-0.13
Currencies: USD
Items
Total Revenue
Revenue
Other Revenue, Total
Cost of Revenue, Total
Gross Profit
Operating Expense
Selling/General/Admin.Expenses,Total
Research & Development
Depreciation/Amortization
Interest Exp.(Inc.), Net-Operating, Total
Unusual Expense (Income)
Other Operating Expenses, Total
Operating Income
Interest Inc.(Exp.),Net-Non-Op.,Total
Gain(Loss) on Sale of Assets
Other, Net
Net Income Before Taxes
Provision for Income Taxes
Net Income After Taxes
Minority Interest
Equity in Affiliates
U.S. GAAP Adjustment
Net Income Before Extra. Items
Total Extraordinary Items
Net Income
Total Adjustments to Net Income
Income Available to Com Excl ExtraOrd
Income Available to Com Incl ExtraOrd
Dilution Adjustment
Diluted Net Income
Diluted Weighted Average Shares
Diluted EPS Excluding ExtraOrd Items
Diluted EPS including ExtraOrd Items
DPS – Common Stock Primary Issue
Diluted Normalized EPS
FY 2025
83.98M
83.98M
--
--
--
369.65M
52.74M
316.90M
--
--
--
--
-285.67M
21.97M
--
--
-263.70M
760.00K
-264.46M
--
--
--
-264.46M
--
-264.46M
--
-264.46M
-264.46M
--
-264.46M
86.67M
-3.05
-3.05
--
-3.05
FY 2024
54.55M
54.55M
--
--
--
267.58M
45.94M
221.63M
--
--
--
--
-213.03M
19.73M
--
--
-193.30M
270.00K
-193.57M
--
--
--
-193.57M
--
-193.57M
--
-193.57M
-193.57M
--
-193.57M
67.12M
-2.88
-2.88
--
-2.88
FY 2023
76.99M
76.99M
--
--
--
232.05M
42.90M
189.15M
--
--
--
--
-155.06M
11.12M
--
--
-143.95M
--
-143.95M
--
--
--
-143.95M
--
-143.95M
--
-143.95M
-143.95M
--
-143.95M
54.34M
-2.65
-2.65
--
-2.65
FY 2022
38.63M
38.63M
--
--
--
222.49M
38.00M
184.50M
--
--
--
--
-183.87M
3.51M
--
--
-180.36M
0.00
-180.36M
--
--
--
-180.36M
--
-180.36M
--
-180.36M
-180.36M
--
-180.36M
48.61M
-3.71
-3.71
--
-3.71
FY 2021
29.75M
29.75M
--
--
--
147.64M
31.20M
116.43M
--
--
--
--
-117.89M
823.00K
--
--
-117.06M
131.00K
-117.19M
--
--
--
-117.19M
--
-117.19M
--
-117.19M
-117.19M
--
-117.19M
42.90M
-2.73
-2.73
--
-2.73

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.